K-h Yeh
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer.
Journal: ESMO open
Published: March 20, 2023
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 09, 2021
JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 28, 2020
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 27, 2018
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 27, 2018
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 21, 2017
High-dose tamoxifen plus ifosfamide and anthracycline in a patient with angiosarcoma of the breast.
Journal: The West Indian medical journal
Published: May 17, 2014
Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity.
Journal: Blood cancer journal
Published: February 13, 2014
A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies.
Journal: British journal of cancer
Published: November 27, 2013
Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: clinical and biological significance.
Journal: Blood cancer journal
Published: March 21, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026